Company news
Nexien Biopharma, Inc. (OTC:NXEN) news
Nexien Biopharma, Inc. news releases on 6ix. Latest, Feb 19, 2021: Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations…
Press releases & updates
Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
February 19, 2021
Nexien BioPharma, Inc. Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2
July 16, 2020
Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity - two common nerve agents
July 18, 2019
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
March 27, 2019
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office
March 5, 2019
Nexien BioPharma to File Pre-IND Meeting Request with the FDA
February 26, 2019
Nexien BioPharma Announces Executive and Business Updates
February 19, 2019
Nexien BioPharma Releases Letter to Shareholders Announcing 2019 Plans, 2018 Activities, and Work to Come From Acquisitions
December 6, 2018
Nexien BioPharma And Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies
November 28, 2018
Uptick Newswire's Stock Day Podcast Interviews Nexien BioPharma CEO, Alex Wasyl, to Discuss the Acquisition of CRX Bio Holdings and The Company’s Future in The Pharmaceutical Space
November 25, 2018
Nexien BioPharma Advances in Clinical Use of a Cannabinoid-Based Formulation for the Treatment of Myotonic Dystrophies and Myotonia
November 5, 2018
Nexien BioPharma Acquires Princeton-Based CRx Bio and Announces Additions to Senior Management
October 29, 2018
INTIVA BioPharma Inc. Announces Name Change to Nexien BioPharma Inc.
September 30, 2018
INTIVA BioPharma (OTCQB: NTVA) Files a Listing Application with the Canadian Securities Exchange (CSE)
August 21, 2018
INTIVA BioPharma Inc (NTVA) Begins Trading on the OTCQB Venture Market
July 18, 2018
OTC Markets Group Welcomes New OTCQB Companies – July 19
July 19, 2018
INTIVA BioPharma Retains Dr. Benedikt Schoser as an Advisor
July 11, 2018